Condition: Dravet Syndrome · Sponsor: The University of Texas Health Science Center, Houston
This study investigates cerebrovascular reactivity (CVR) and functional brain connectivity in Dravet Syndrome (DS) patients with convulsive seizures. Using functional MRI (fMRI), we will define differences in brain responses to CO₂ changes before administration of the drug Fintepla (Baseline), with a library of healthy controls and with those obtained after administration of Fintepla (Day \~60). Changes in CVR and their relation to ventilatory responses will also be assessed during fMRI.
This description comes directly from the study's public registry record.
Samden Lhatoo, MD, FRCP · (713) 500-7106 · Samden.D.Lhatoo@uth.tmc.edu
Sandhya Rani · (713) 500-7499 · M.R.Sandhya.Rani@uth.tmc.edu
Always discuss trial participation with your own doctor first.
| The University of Texas Health Science Center at Houston | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07112365